Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

SAN DIEGO–(BUSINESS WIRE)—- $JANX–Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Read More

Business Wire Stock Sale/Buyback News

Enjoying Merger Arbitrage Limited?

Enjoying Merger Arbitrage Limited?

Sign up then! It's quick and FREE

Have time to share an article? It's very much appreciated!!

You have Successfully Subscribed!